|

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

RECRUITINGSponsored by University of California, San Francisco
Actively Recruiting
SponsorUniversity of California, San Francisco
Started2023-12-20
Est. completion2034-02-28
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations4 sites
View on ClinicalTrials.gov →

NCT05964504

Summary

This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
2. Age \>=18 years
3. Any receptor subtype.
4. Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria:

1. Stage I-III breast cancer.
2. Lack of lobular histology on tumor biopsy.
3. Other active cancer (prior treated cancer with no current evidence of disease is allowed).

Conditions4

Breast CancerCancerLobular Breast CarcinomaMetastatic Breast Cancer

Locations4 sites

California

2 sites
University of California, San Diego
San Diego, California, 92053
University of California, San Francisco
San Francisco, California, 94122
Astrid Quirarte415-476-8390Astrid.Quirarte@ucsf.edu

Pennsylvania

1 site
Abramson Cancer Center
Philadelphia, Pennsylvania, 19104

Texas

1 site
MD Anderson Cancer Center
Houston, Texas, 77030

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.